Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Advanced Bladder Cancer × Genitourinary × Clear all

Phase

Phase 3 1 Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 450 Urinary Bladder Neoplasms 126 Carcinoma, Renal Cell 107 Neoplasms 56 Kidney Neoplasms 47 Non-Muscle Invasive Bladder Neoplasms 39 Neoplasm Metastasis 35 Carcinoma, Transitional Cell 34 Testicular Neoplasms 24 Breast Neoplasms 24 Recurrence 19 Parkinson Disease 4, Autosomal Dominant Lewy Body 14 Wilms Tumor 13 Testicular Germ Cell Tumor 11 Seminoma 11 Pain 11 Ovarian Neoplasms 10 Multiple Myeloma 10 Carcinoma 10 Burkitt Lymphoma 10 Teratoma 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Osteoporosis 9 Lymphoma, Large B-Cell, Diffuse 9 Lung Neoplasms 9 Urologic Neoplasms 8 Urethral Neoplasms 8 Lymphoma, Non-Hodgkin 8 Lymphoma, Mantle-Cell 8 Lymphoma, Large-Cell, Immunoblastic 8

Interventions

pembrolizumab 1 enfortumab vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07346053 2026-01-16

Chrono-EVP

British Columbia Cancer Agency

Phase 3 Not yet recruiting

Advanced Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡